Is there a sufficient evidence for cardioprotective effects of mild wine consumption on cardiovascular diseases?
Authors:
M. Táborský; P. Ošťádal; M. Petřek; P. Heinc; J. Václavík; M. Lazárová; J. Vítovec
Published in the journal:
Kardiol Rev Int Med 2010, 12(4): 192-196
Category:
Angiological Symposium
Summary
Mild alcohol consumption decreases cardiovascular morbidity and mortality as well as it reduces total mortality. Although regular intake of any type of alcoholic beverage appears to have positive influence on health, additional benefits are thought to be associated with wine, particularly red wine. The beneficial effect of wine is ascribed to the presence of ethanol and phenolic substances. This overview is dedicated to epidemiology of coronary artery disease (CAD) and wine consumption, as well as the underlying mechanisms of the biological effects of wine compounds on CAD.
Keywords:
wine – ethyl alcohol – antioxidants – flavonoids
Zdroje
1. Evans A. Dr. Black´s favorite disease. Br Heart J 1995; 74: 696-697.
2. St. Leger AS, Cochrane AL, Moore F et al. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; 1: 1017–1020.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523–1526.
4. Šamánek M. Snižuje mírné pití alkoholu výskyt i úmrtnost na ischemickou chorobu srdeční? Čas Lék čes 2000; 139: 747–752.
5. Šamánek M, Dobiášová M, Urbanová Z et al. Pití bílého vína k večeři oddaluje aterosklerózu a působí antikoagulačně. Čas Lék čes 2002; 141: 251–254.
6. Providęncia R. Cardiovascular protection from alcoholic drinks: scientific basic of the French paradox. Rev Potr Cardiol 2006; 25: 1043–1058.
7. Albert CM, Manson JE, Cook NR et al. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999; 100: 944–950.
8. Mukamal KJ, Conigrave KM, Mittleman MA et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109–118.
9. Fuchs FD, Chambless LE, Folsom AR et al. Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004; 160: 466–474.
10. Klatsky AL, Friedman GD, Armstrong MA et al. Wine, liquor, beer, and mortality. Am J Epidemiol 2003; 158: 585–595.
11. Lowry F. Alcohol cuts risk for heart disease by one third. 2009. [http://cme.medscape.com/viewarticle/713107/].
12. Grønbaek M, Deis A, Sørensen TI et al. Mortality associated with moderate intakes of wine, beer or spirits. BMJ 1995; 310: 1165–1169.
13. Grønbaek M, Becker U, Johansen D et al. Type of alcohol consumed and mortality from all causes, coronary artery disease, and cancer. Ann Intern Med 2000; 133: 411–419.
14. Renaud SC, Guéguen R, Siest G et al. Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med 1999; 159: 1865–1870.
15. Sharper AG, Wannammethee SG. Alcohol intake and mortality in middle agend men with diagnosed coronary disease. Heart 2000; 83: 394–399.
16. Mukamal KJ, Maclure M, Mulller JE et al. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 2001; 285: 1965–1970.
17. de Lorgeril M, Salen P, Martin JL et al. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circullation 2002; 106: 1465–1469.
18. van de Wiel A, van Golde PH, Hart HC. Blessings of the grape. Eur J Intern Med 2001; 12: 484–489.
19. Corder R. The wine diet. London, UK: Sphere 2000: 1–256.
20. Bertelli AAE. Wine, research and cardiovascular disease: Instruction for use. Atherosclerosis 2007; 195: 242–247.
21. Bertelli AAE, Migliori M, Panichi V et al. Oxidative stress and inflammatory reaction modulation by white wine. Ann N Y Acad Sci 2002; 957: 295–301.
22. Corder R, Mullen W, Khan NQ et al. Oenology: red wine procyanidins and vascular health. Nature 2006; 444: 566.
23. Toufektsian MC, de Lorgeril M, Nagy N et al. Protection against myocardial infartion after long-term chronic dietary intake of plant-derived anthocyanins protects the rat heart against regional ischemia-reperfusion injury. J Nutr 2008; 138: 747–752.
24. Ferrali M, Signorini C, Caxiott B et al. Protection against oxidative dammage of erytrocyte membrane by flavonoid quercentin and its relation to iron chelating activity. FEBS Lett 1997; 416: 123–129.
25. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The in-vivo evidence. Nat Rev Drug Discov 2006; 5: 493–506.
26. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 2006; 6: 36–47.
27. Thirunavukkarasu M, Penumathsa SV, Koneru S et al. Resveratrol alleviates cardiac dysfunction in streptozocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 2007; 43: 720–729.
28. Dell´Agli M, Buscialŕ A, Bosisio E. Vascullar effects of wine polyfenols. Cardiovasc Res 2004; 63: 593–602.
29. Sacanella E, Vázquez-Agell M, Mena MP et al. Down-regullation of adhesion molecules and other inflammatory biomarkers after moderate wine consumpption in healthy women: a randomized trial. Am J Clin Nutr 2007; 86: 1463–1469.
30. Mukammal KJ, Maclure M, Muller JE et al. Binge drinking and mortality after acute myocardial infarction. Circulation 2005; 112: 3839–3845.
31. WHO. Alcohol and injuries: Emergency department studies in an international perspective. 2010. [http://www.who.int/substance_abuse/publications/alcohol/en/index.html].
32. The ONTARGET Investigator. Yusuf S, Teo KK, Pogue J, Dyal L et al. Telmisartan, Ramipril, or Both at High Risk for Vascular Events. N Engl J Med 2008; 358: 1547–1559.
33. Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ 2009; 338: b2337.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2010 Číslo 4
Najčítanejšie v tomto čísle
- Aortitis – an inflammation of the aortic wall
- Thrombolytic therapy of acute central retinal artery occlusion
- Rare popliteal artery diseases
- Small aneurysms of abdominal aorta – is it time to change our approach?